Skip to main content

Table 2 Clinical characteristics of patients with high or low VDJ%

From: In non-transplant patients with multiple myeloma, the pre-treatment level of clonotypic cells predicts event-free survival

 

High VDJ%

High VDJ%

Low VDJ%

Low VDJ%

High VDJ%

Low VDJ%

Remission Samples

  

Unt/Ch

RR/Ch

Unt/Ch

RR/Ch

ASCT

ASCT

 

Age

≥65

11/16

12/24

20/24

13/25

5/29

6/21

11/33

Albumin

>30

13/15

23/24

20/24

24/24

26/27

19/21

27/28

β2M

≥3

12/14

16/21

16/19

14/22

18/24

9/18

18/26

Calcium

≥2.5

1/14

8/23

5/24

5/24

7/26

6/21

11/29

Creatinine

≥177

3/14

5/24

6/24

0/24

7/28

1/21

4/29

Hemoglobin

>100

8/16

13/24

18/24

20/24

15/29

14/20

23/30

LDH

>618

6/14

2/24

2/22

2/23

6/25

1/21

3/28

t(4;14)

Positive

0/12

3/15

3/18

2/19

2/20

2/15

5/29

Stage

III

7/14

10/21

9/19

8/22

8/23

5/18

10/25

  1. Unt=Untreated, RR = relapse/refractory, Ch = only conventional chemotherapy.